现行高钾血症干预联合10%葡萄糖溶液可显著降低低血糖发生率(CHICA-D10)
该回顾性研究比较新旧成人急性高钾血症医嘱集对低血糖发生率的影响。新医嘱集将静脉常规胰岛素从10单位减至5单位,并在胰岛素前血糖≤250 mg/dL时,除静推50%葡萄糖50 mL外,加用10%葡萄糖250 mL静脉输注2小时。纳入肾清除受损(肌酐清除率<30 mL/min或依赖透析)、胰岛素前血钾>5.5 mmol/L且血糖≤250 mg/dL的成人。每组100例,新组低血糖(血糖<70 mg/dL)6例(6%) vs 旧组20例(20%)(p=0.003),两组胰岛素后血钾≤5.5 mmol/L的患者数无显著差异。
要点
- 新医嘱集低血糖发生率6%(6/100) vs 旧医嘱集20%(20/100),p=0.003,适用于肾清除受损且胰岛素前血糖≤250 mg/dL的成人高钾血症患者。
- 新医嘱集将静脉常规胰岛素剂量从10单位减至5单位,并加用10%葡萄糖250 mL静脉输注2小时联合50%葡萄糖50 mL静推。
- 两组胰岛素前血钾中位数分别为6.4 mmol/L(旧组)和6.3 mmol/L(新组),p=0.133;胰岛素前血糖中位数分别为120 mg/dL(旧组)和107.5 mg/dL(新组),p=0.013。
- 两组达到胰岛素后血钾≤5.5 mmol/L的患者数无显著差异。
- 背景指出单次葡萄糖与胰岛素同时给药方案不足,低血糖常发生于胰岛素给药后60分钟并可持续至给药后两小时。
适用人群与场景
- 成人,从医嘱集接受静脉常规胰岛素并在到达急诊科6小时内给药,胰岛素前血钾>5.5 mmol/L,胰岛素前血糖≤250 mg/dL,且肾清除受损(肌酐清除率<30 mL/min或依赖透析)。
诊断标准与关键阈值
- 低血糖定义为血糖<70 mg/dL。
- 肾清除受损定义为肌酐清除率<30 mL/min或依赖透析。
处置流程与药物剂量
- 新医嘱集将静脉常规胰岛素剂量从10单位减至5单位。
- 若胰岛素前血糖≤250 mg/dL,在静脉常规胰岛素同时静推50%葡萄糖50 mL,并额外给予10%葡萄糖250 mL静脉输注2小时。
研究设计与关键结果
- 回顾性研究,每组100例;新医嘱集组低血糖6例(6%) vs 旧医嘱集组20例(20%),p=0.003。
- 胰岛素前血钾中位数:旧组6.4 mmol/L vs 新组6.3 mmol/L,p=0.133;胰岛素前血糖中位数:旧组120 mg/dL vs 新组107.5 mg/dL,p=0.013。
- 两组达到胰岛素后血钾≤5.5 mmol/L的患者数无显著差异。
证据类型、等级与局限
- 回顾性研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在治疗启动时额外给予10%葡萄糖250 mL与显著降低的低血糖发生率相关。
- 作者认为,如果采用额外的预防措施,脆弱人群的低血糖发生率可显著降低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Current protocols which include the administration of a single dextrose dose concomitantly with insulin are inadequate as hypoglycemia commonly occurs 60 min after insulin administration and may persist for up to two hours post-insulin administration. To prevent delayed hypoglycemic events, our institution revised our adult acute hyperkalemia order set to include hypoglycemic preventative measures not currently described in the literature.
METHODS: The primary purpose of this retrospective study was to determine if the new adult acute hyperkalemia order set resulted in lower rates of hypoglycemia (glucose <70 mg/dL) compared to the old order set in patients with impaired renal clearance and lower pre-insulin glucose values. In addition to reducing the IV regular insulin dose from 10 to 5 units, the new order set recommends patients receive a 250 mL dextrose 10% solution over two hours in addition to a 50 mL dextrose 50% IV push concomitantly with IV regular insulin if their pre-insulin glucose is ≤250 mg/dL. Patients were included if they were adults, received IV regular insulin from the order set within six hours of presenting to the ED, had a pre-insulin potassium >5.5 mmol/L, had a pre-insulin glucose ≤250 mg/dL, and had impaired renal clearance [creatinine clearance (CrCl) < 30 mL/min or dialysis dependent].
RESULTS: 100 patients were included in each arm. The median pre-insulin potassium levels were 6.4 mmol/L and 6.3 mmol/L in the old and new groups, respectively (p = 0.133). The median pre-insulin glucose levels were 120 mg/dL and 107.5 mg/dL in the old and new groups, respectively (p = 0.013). Twenty (20%) patients in the old group developed hypoglycemia, whereas six (6%) patients in the new group developed hypoglycemia (p = 0.003). There was no significant difference between the two groups in number of patients who achieved a post-insulin potassium level ≤ 5.5 mmol/L.
CONCLUSION: Our study found that our approach of additionally administering a 250 mL dextrose 10% solution upon therapy initiation is associated with significantly lower rates of hypoglycemia. Our findings indicate that hypoglycemia rates can be significantly reduced in vulnerable populations if additional preventative measures are employed.
参考来源
- Ibarra F, Fountain C, Fallert T, et al. Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10). Am J Emerg Med. 2024. PMID: 39111100. doi:10.1016/j.ajem.2024.07.061
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。